Founded by Jonathan Cohen, 20/20 BioLabs develops and commercializes AI-powered laboratory blood tests aimed at detecting cancer and chronic disease earlier. Its OneTest for Cancer uses a protein tumor-marker approach and can be collected at home with an upper-arm device, while the company’s longevity test measures inflammation-related biomarkers to support proactive health decisions. The company’s laboratory is CAP accredited and CLIA licensed, and its multi-cancer test has performed in blinded studies conducted by the U.S. National Cancer Institute.
CAP Accredited Laboratory
certification
CLIA Licensed Laboratory
registration